CDKN2A and non-small cell lung carcinoma: DNMT1 has been shown to be specifically over-expressed in NSCLC lung tumours compared to normal cells where DNMT1 over-expression resulted in increased methylation of the TSGs, FHIT, p16INK4a and RARβ21.